Please enable JS

Investors & Media

2014 News Releases

Keyword Search
2018 | 2017 | 2016 | 2015 | 2014
Nov-10-2014CRISPR Therapeutics Founding Scientist, Emmanuelle Charpentier Awarded 2015 Breakthrough Prize in Life Sciences
Basel, Switzerland – 10 November 2014 CRISPR Therapeutics, a biopharmaceutical company focused on the gene-editing technology CRISPR-Cas9, today announced that Dr Emmanuelle Charpentier, a co-founder and advisor to the Company, has been awarded the 2015 Breakthrough Prize in Life Sciences. Dr Charpentier, head of the Regulation in Infection Biology department at the Helmholtz-Zentrum für Infektionsforschung (Helmholtz Centre for Infection Research) in Braunschweig, Germany, ... 
Printer Friendly Version
Apr-24-2014CRISPR Therapeutics Raises $25 million in Series A Financing and Announces Founding Team of World-Renowned Academics and Clinicians
Basel, Switzerland – 24 April 2014 CRISPR Therapeutics, a biopharmaceutical company focused on the breakthrough gene-editing technology CRISPR-Cas9, has raised $25 million in a series A investment from Versant Ventures. The company today also announced a founding team comprising high-profile experts in diverse fields of science including CRISPR-Cas9, genome editing, stem cell biology, advanced drug delivery technologies, RNA interference and gene silencing. ... 
Printer Friendly Version
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet